Related references
Note: Only part of the references are listed.Incidence, Predictors, and Outcomes of Gastrointestinal Bleeding in Patients on Dual Antiplatelet Therapy With Aspirin and Clopidogrel
Oluseun Alli et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2011)
Calcium-Channel Blockers Do Not Alter the Clinical Efficacy of Clopidogrel After Myocardial Infarction A Nationwide Cohort Study
Jonas B. Olesen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Efficacy and Safety of Glycoprotein IIb/IIIa Inhibitors During Elective Coronary Revascularization A Meta-Analysis of Randomized Trials Performed in the Era of Stents and Thienopyridines
David E. Winchester et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
Neena S. Abraham et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
LESS IS MORE Risk of Bleeding With Single, Dual, or Triple Therapy With Warfarin, Aspirin, and Clopidogrel in Patients With Atrial Fibrillation
Morten L. Hansen et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Famotidine Is Inferior to Pantoprazole in Preventing Recurrence of Aspirin-Related Peptic Ulcers or Erosions
Fook-Hong Ng et al.
GASTROENTEROLOGY (2010)
Calcium-channel blockers decrease clopidogrel-mediated platelet inhibition
Thomas Gremmel et al.
HEART (2010)
Retroperitoneal Hematoma After Percutaneous Coronary Intervention: Prevalence, Risk Factors, Management, Outcomes, and Predictors of Mortality A Report From the BMC2 (Blue Cross Blue Shield of Michigan Cardiovascular Consortium) Registry
Santi Trimarchi et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2010)
Association Between Use of Bleeding Avoidance Strategies and Risk of Periprocedural Bleeding Among Patients Undergoing Percutaneous Coronary Intervention
Steven P. Marso et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Incidence of Dyspnea and Assessment of Cardiac and Pulmonary Function in Patients With Stable Coronary Artery Disease Receiving Ticagrelor, Clopidogrel, or Placebo in the ONSET/OFFSET Study
Robert F. Storey et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Comparison of ticagrelor with clopidogrel in patients with planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study
Christopher P. Cannon et al.
LANCET (2010)
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial
Shamir R. Mehta et al.
LANCET (2010)
Clopidogrel with or without Omeprazole in Coronary Artery Disease.
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Mechanism of action and clinical development of ticagrelor, a novel platelet ADP P2Y(12) receptor antagonist
Davide Capodanno et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2010)
Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial
Ali S. Taha et al.
LANCET (2009)
Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials
Michelle L. O'Donoghue et al.
LANCET (2009)
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Risk and management of upper gastrointestinal bleeding associated with prolonged dual-antiplatelet therapy after percutaneous coronary intervention
Victoria P. Tan et al.
CARDIOVASCULAR REVASCULARIZATION MEDICINE (2009)
Prevalence of comorbidity of chronic diseases in Australia
Gillian E. Caughey et al.
BMC PUBLIC HEALTH (2008)
Statins do not adversely affect post-interventional residual platelet aggregation and outcomes in patients undergoing coronary stenting treated by dual antiplatelet therapy
Tobias Geisleri et al.
EUROPEAN HEART JOURNAL (2008)
Benefits and risks with antiplatelet therapy: how great a problem is bleeding?
Steen Husted
EUROPEAN HEART JOURNAL SUPPLEMENTS (2008)
Trends in the Prevalence and Outcomes of Radial and Femoral Approaches to Percutaneous Coronary Intervention A Report From the National Cardiovascular Data Registry
Sunil V. Rao et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2008)
Calcium-Channel Blockers Reduce the Antiplatelet Effect of Clopidogrel
Jolanta M. Siller-Matula et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Clinical review: gastrointestinal bleeding after percutaneous coronary intervention: a deadly combination
P. Foley et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2008)
Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention - The prasugrel in comparison to clopidogrel for inhibition of platelet activation and aggregation-thrombolysis in myocardial infarction 44 trial
Stephen D. Wiviott et al.
CIRCULATION (2007)
Prasugrel: A novel thienopyridine antiplatelet agent. A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profile
Joseph A. Jakubowski et al.
CARDIOVASCULAR DRUG REVIEWS (2007)
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Stephen D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Predictors and impact of major Hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 trial
Frederick Feit et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Predictive and protective factors associated with upper gastrointestinal bleeding after percutaneous coronary intervention: A case-control study
Marcus W. S. Chin et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Relationship between central sympathetic drive and magnetic resonance Imaging-determined left ventricular mass in essential hypertension
Markus P. Schlaich et al.
CIRCULATION (2007)
Drug Insight: cyclo-oxygenase-2 inhibitors - a critical appraisal
Burkhard Hinz et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2007)
Clinical aspects of platelet inhibitors and thrombus formation
Telly A. Meadows et al.
CIRCULATION RESEARCH (2007)
Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants
Angel Lanas et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
DL Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Effect of clopidogrel premedication in off-pump cardiac surgery - Are we forfeiting the benefits of reduced hemorrhagic sequelae?
EI Kapetanakis et al.
CIRCULATION (2006)
Aspirin, warfarin and a thienopyridine for acute coronary syndromes
Y Konstantino et al.
CARDIOLOGY (2006)
Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes
KP Alexander et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial
ZM Chen et al.
LANCET (2005)
The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes - Results from the CRUSADE National Quality Improvement Initiative
G Yang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Balancing the benefit and risk of oral antiplatelet agents in coronary artery bypass surgery
CP Cannon et al.
ANNALS OF THORACIC SURGERY (2005)
The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromes
JV Mitsios et al.
PLATELETS (2005)
Analysis of risk of bleeding complications after different doses of Aspirin in 192,036 patients enrolled in 31 randomized controlled trials
VL Serebruany et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction
K Buresly et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation
MS Sabatine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist's panacea or the surgeon's headache?
EI Kapetanakis et al.
EUROPEAN HEART JOURNAL (2005)
Clopidogrel-related refractory bleeding after coronary artery bypass graft surgery: A rationale for the use of coagulation factor concentrates?
C von Heymann et al.
HEART SURGERY FORUM (2005)
Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devices
HMO Farouque et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes
JV Mitsios et al.
CIRCULATION (2004)
Massive nasal bleeding and hemodynamic instability associated with clopidogrel
FE Nácul et al.
PHARMACY WORLD & SCIENCE (2004)
A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel
A Kastrati et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical Revascularization for non-ST-elevation acute coronary syndrome - The Clopidogrel in Unstable Angina to prevent Recurrent Ischemic Events (CURE) trial
KAA Fox et al.
CIRCULATION (2004)
Antiplatlet effects of a 600 mg loading dose of clopidogrel are not attenuated in patients receiving atorvastatin or simvastatin for at least 4 weeks prior to cononary artery stenting
O Gorchakova et al.
EUROPEAN HEART JOURNAL (2004)
Absence of interaction between atorvastatin or other statins and clopidogrel - Results from the interaction study
VL Serebruany et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes - Observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study
RJG Peters et al.
CIRCULATION (2003)
Lipophilic statins interfere with the inhibitory effects of clopidogrel on platelet function -: a flow cytometry study
H Neubauer et al.
EUROPEAN HEART JOURNAL (2003)
Predictors of major bleeding in acute coronary syndromes:: the Global Registry of Acute Coronary Events (GRACE)
M Moscucci et al.
EUROPEAN HEART JOURNAL (2003)
American Heart Association/American College of Cardiology Foundation guide to warfarin therapy
J Hirsh et al.
CIRCULATION (2003)
Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation - A new drug-drug interaction
WC Lau et al.
CIRCULATION (2003)
ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-Segment elevation myocardial infarction - Summary article - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina)
E Braunwald et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Antiplatelet strategies
C Patrono
EUROPEAN HEART JOURNAL SUPPLEMENTS (2002)
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes:: a meta-analysis of all major randomised clinical trials
E Boersma et al.
LANCET (2002)
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
SR Mehta et al.
LANCET (2001)
Thrombocytopenia complicating treatment with intravenous glycoprotein IIb/IIIa receptor inhibitors: A pooled analysis
H Dasgupta et al.
AMERICAN HEART JOURNAL (2000)
Thrombotic thrombocytopenic purpura associated with clopidogrel.
CL Bennett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Clinical challenges of platelet glycoprotein IIb/IIIa receptor inhibitor therapy: Bleeding, reversal, thrombocytopenia, and retreatment
JE Tcheng
AMERICAN HEART JOURNAL (2000)
Share Paper
